Abortion, Missed Clinical Trial
Official title:
Use of Fetoscopy in Missed Abortion
The purpose of this study is to evaluate the use of hysteroscopic embryoscopy or fetoscopy as a powerful diagnostic tool to provide better counseling for couples having experienced pregnancy loss.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | January 2021 |
Est. primary completion date | January 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Women diagnosed with missed abortion during the first trimester of pregnancy Exclusion Criteria: - Women diagnosed with missed abortion after the first trimester of pregnancy - Any contraindication for hysteroscopy |
Country | Name | City | State |
---|---|---|---|
Israel | Hille Yaffe Medical Center | Hadera |
Lead Sponsor | Collaborator |
---|---|
Hillel Yaffe Medical Center |
Israel,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Macroscopic anatomic malformations in missed abortions | The number and type of macroscopic anatomic malformations in missed abortions will be determined through visual observation using a fetoscope | Two years | |
Secondary | Minimize intrauterine adhesions through observation | To minimize intrauterine adhesions that might occur after curettage through the ability to visualize the womb and pregnancy site through a hysteroscope before the surgical procedure so that inadvertent intrauterine adhesions are minimized. After one year, if pregnancy is not achieved (due to intrauterine adhesions that cause infertility), a follow-up hysteroscopy will be performed and intrauterine adhesions can be visualized if they have occurred. | Two years | |
Secondary | Prevention of retained conception products | Prevention of retained conception products by hysteroscopy after curettage and visualization and observation of the contents of the womb | Two years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04499976 -
Isonicotinic Acid Hydrazide Pretreatment With Misoprostol Induction of Abortion in First-trimester Missed Miscarriage
|
Phase 4 | |
Active, not recruiting |
NCT03736681 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage
|
Phase 1 | |
Completed |
NCT03636451 -
Effect of Paracervical Block Volume on Pain Control for Dilation and Curettage.o
|
Phase 3 | |
Recruiting |
NCT05124314 -
Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss
|
Phase 4 | |
Recruiting |
NCT02917785 -
Testing the Efficiency of Karman Curette in the Treatment of Misoprostol Failure in Women With Missed Abortion
|
N/A | |
Completed |
NCT04906278 -
Amniotomy for Second-trimester Pregnancy Termination
|
N/A | |
Completed |
NCT03148314 -
Vaginal Misoprostol In Management Of First Trimester Missed Abortion.
|
Phase 2 | |
Completed |
NCT00784797 -
Misopristol Versus Pitocin for Second Trimester Abortion
|
Phase 4 | |
Completed |
NCT03767179 -
Research of Serum Procalcitonin, ESR, CRP And Leukocyte Levels in Fertile Missed Abortion Cases
|
||
Completed |
NCT02515604 -
Comparison of Single and Repeated Dose of Vaginal Misoprostol for the Treatment of Early Pregnancy Failure
|
Phase 4 | |
Completed |
NCT00410345 -
Cervical Rippening With Antiprogesterone in Midtrimester Abortions
|
Phase 4 |